Latest news with #AstoneaLabs
Business Standard
16 hours ago
- Business
- Business Standard
BSE SME Astonea Labs inches higher on debut
Shares of Astonea Labs was trading at Rs 138.90 on the BSE, a premium of 2.89% compared with the issue price of Rs 135. The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public offer (IPO) price. The stock was currently up 1.05% over its listing price. The counter hit a high of Rs 140 and a low of Rs 136.15. About 5.03 lakh shares of the company changed hands at the counter. Astonea Labs' IPO was subscribed 2.44 times. The issue opened for bidding on 27 May 2025 and it closed on 29 May 2025. The price band of the IPO was set at Rs 128-135 per share. The IPO comprised fresh issue of 20,00,000 shares. The promoter and promoter shareholding diluted to 72.30% from 98.42% pre-IPO. The company intends to utilize the net proceeds for expenses related to product registration in Bolivia (South America), purchase and installation of plant and machinery for export-grade ointment production at its Haryana facility, advertising, marketing and brand building, investment in hardware and software, working capital requirements, and general corporate purposes. Ahead of the IPO, Astonea Labs on 26 May 2025, raised Rs 10.66 crore from anchor investors. The board allotted 7,90,000 shares at Rs 135 per share to 4 anchor investors. Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynaecological concerns, analgesics, fungal infections, and multivitamins. It also offers products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums. The company has total 217 employees. The company recorded revenue from operations of Rs 69.55 crore and net profit of Rs 4.10 crore for the period ended 31 December 2024.
Time of India
21 hours ago
- Business
- Time of India
Astonea Labs set to list today: Muted GMP signals flat debut
Astonea Labs is all set to debut on the BSE SME platform on Tuesday, June 3, following the completion of its Rs 37.67 crore initial public offering (IPO). The IPO, which was open for subscription from May 27 to May 29, received a modest response from investors and is now showing zero premium in the grey market, hinting at a flat listing. As per the latest grey market data, the last traded grey market premium (GMP) for Astonea Labs is Rs 0. With the IPO price fixed at the upper band of Rs 135 per share, the estimated listing price is expected to remain at Rs 135, reflecting no expected gains or losses on listing. The IPO was entirely a fresh issue of 27.90 lakh shares, and the proceeds are to be used for a mix of expansion plans, including registration in Bolivia, setting up an ointment production unit for exports, advertising, tech upgrades, working capital, and general corporate purposes. Astonea Labs, incorporated in 2017, is engaged in the contract manufacturing of pharmaceutical and cosmetic products. Its portfolio includes skincare and healthcare products under the brands "Glow Up" and "Regero", with plans to launch a new brand 'Avicel.' The company exports to markets like Iraq and Yemen and trades packaging and raw materials within the industry. The IPO was subscribed 1.79 times overall. The retail category was subscribed 1.69 times, QIB just 0.70 times, while the NII portion saw the strongest demand at 5.60 times. Despite its strong financial performance in FY24 — including a jump in net profit to Rs 3.81 crore from Rs 0.67 crore in FY23 — the lukewarm subscription and zero GMP suggest limited excitement among investors. Analysts say the SME stock's fully priced valuation and sector-specific risks may have kept some bidders on the sidelines. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Economic Times
21 hours ago
- Business
- Economic Times
Astonea Labs set to list today: Muted GMP signals flat debut
Astonea Labs is all set to debut on the BSE SME platform on Tuesday, June 3, following the completion of its Rs 37.67 crore initial public offering (IPO). The IPO, which was open for subscription from May 27 to May 29, received a modest response from investors and is now showing zero premium in the grey market, hinting at a flat listing. ADVERTISEMENT As per the latest grey market data, the last traded grey market premium (GMP) for Astonea Labs is Rs 0. With the IPO price fixed at the upper band of Rs 135 per share, the estimated listing price is expected to remain at Rs 135, reflecting no expected gains or losses on listing. The IPO was entirely a fresh issue of 27.90 lakh shares, and the proceeds are to be used for a mix of expansion plans, including registration in Bolivia, setting up an ointment production unit for exports, advertising, tech upgrades, working capital, and general corporate purposes. Astonea Labs, incorporated in 2017, is engaged in the contract manufacturing of pharmaceutical and cosmetic products. Its portfolio includes skincare and healthcare products under the brands "Glow Up" and "Regero", with plans to launch a new brand 'Avicel.' The company exports to markets like Iraq and Yemen and trades packaging and raw materials within the IPO was subscribed 1.79 times overall. The retail category was subscribed 1.69 times, QIB just 0.70 times, while the NII portion saw the strongest demand at 5.60 its strong financial performance in FY24 — including a jump in net profit to Rs 3.81 crore from Rs 0.67 crore in FY23 — the lukewarm subscription and zero GMP suggest limited excitement among investors. ADVERTISEMENT Analysts say the SME stock's fully priced valuation and sector-specific risks may have kept some bidders on the sidelines. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Mint
4 days ago
- Business
- Mint
Astonea Labs IPO allotment to be out soon: Here are Steps to check status online and GMP as focus shifts to listing
Astonea Labs IPO: The allotment for the IPO that saw its subscription period end on 29 May, is to be out soon: Kfin Technologies Limited is the issue's registrar, while Oneview Corporate Advisors Pvt. Ltd. is the book-running lead manager for the Astonea Labs IPO. On Friday, May 30, 2025, the allotment of shares for Astonea Labs' initial public offering will be finalized. The proposed listing date for Astonea Labs' initial public offering (IPO) is on the BSE SME is set for Tuesday, June 3, 2025. Since the Kfin Technologies Limited is the registrar to the issue and the Astonea Labs shares are to be listed on BSE SME Investors can check allotments status for Astonea Labs IPO either on the registrars website or the BSE Step 1: Go to the website of Registrar Kfin Technologies Limited to check Astonea Labs allotment status by clicking the link: Step 2: Select any of the link windows for checking the Astonea Labs IPO allotment status Step 3: Select Astonea Labs Limited' from the 'Select IPO' dropdown menu. Step 4: Select any of the following, from Demat number, application number or the PAN number Step 5: Enter the details from the option selected Step 7: Click on the submit button Step 1: Go to the BSE website for chrcking Astonea Labs IPO allotment and click the link: Step 2: Select the issue type Step 3: Select the IPO or "Astonea Labs Limited' from the Issue name ' dropdown menu. Step 4: Select any of the following — DPID or Demat number, application number or the PAN number Step 5: Enter the details from the option selected Step 7: Click the submit button Astonea Labs IPO GMP or Grey Market Premium stands at Nil . This means that the Astonea Labs shares are available without any premium over the issue price price of ₹ 135 in the grey market. The same also means that the market participants are noy expecting any listing gains and the listing of Astonea Labs shares is expected to be at close to the upper band of the offer price of ₹ 135 a piece, as suggested by data Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Astonea Labs IPO allotment today; check latest GMP, steps to verify status
Astonea Labs IPO allotment status: The basis of allotment of shares for Astonea Labs is expected to be finalised today, Friday, May 30, 2025. The initial public offering (IPO) of Astonea Labs, which closed for subscription on Thursday, May 29, received a muted response from investors, with the offering being oversubscribed by nearly 1.8 times. Once the allotment is finalised, investors can check their status on the official websites of the BSE and Kfin Technologies, the registrar for the Astonea Labs IPO. Alternatively, investors can also follow these direct links to check the Astonea Labs IPO allotment status online: Check Astonea Labs IPO allotment status on BSE: Check Astonea Labs IPO allotment status on Kfin Technologies: Astonea Labs IPO details The SME offering, valued at around ₹37.67 crore, comprises an entirely fresh issue of 2.79 million equity shares with no offer for sale (OFS) component. The public issue was open for subscription from Tuesday, May 27, 2025, to Thursday, May 29. Astonea Labs IPO was available at the price band of ₹128 to ₹135 per share, with a lot size of 1,000 shares. Kfin Technologies serves as the registrar, while Oneview Corporate Advisors acts as the sole book-running lead manager for the offering. According to the RHP, the company aims to utilise the issue proceeds for funding of expenses proposed to be incurred towards registration in Bolivia, South America; purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the second floor of the existing premises; advertising, marketing and brand building; investment in procuring hardware and software and funding of working capital requirements. The remaining funds will be used for general corporate purposes. Check Blue Water Logistics IPO allotment status About Astonea Labs Incorporated in 2017, Astonea Labs is a contract manufacturer of pharmaceutical and cosmetic products for companies both within India and internationally. The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more. The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards. The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands Glow Up and Regero, plans to launch Avicel, and exports to countries like Iraq and Yemen.
